dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | García Martínez, Rafael |
dc.contributor.author | Sanz Gea, Clara |
dc.contributor.author | Martin Riera, Victor |
dc.contributor.author | Guerra-Ruiz, Armando |
dc.contributor.author | Paciucci Barzanti, Rosanna |
dc.contributor.author | Ferrer Costa, Roser |
dc.contributor.author | Ramírez Serra, Clara |
dc.date.accessioned | 2023-05-10T06:47:20Z |
dc.date.available | 2023-05-10T06:47:20Z |
dc.date.issued | 2023-04-18 |
dc.identifier.citation | García Martínez RJ, Sanz Gea C, Martin-Riera V, Raúl A, Ruiz G, Paciucci Barzanti R, et al. Dasatinib-Induced Chylothorax: A Clinical Laboratory’s Perspective. EJIFCC. 2023 Apr 18;34(1):76. |
dc.identifier.issn | 1650-3414 |
dc.identifier.uri | https://hdl.handle.net/11351/9488 |
dc.description | Dasatinib; Vessament pleural quilotòrax |
dc.language.iso | eng |
dc.publisher | International Federation of Clinical Chemistry and Laboratory Medicine |
dc.relation.ispartofseries | EJIFCC;34(1) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Proteïnes quinases - Inhibidors - Efectes secundaris |
dc.subject | Embassament pleural |
dc.subject.mesh | Protein Kinase Inhibitors |
dc.subject.mesh | /adverse effects |
dc.subject.mesh | Chylothorax |
dc.subject.mesh | /chemically induced |
dc.title | Dasatinib-induced chylothorax: a clinical laboratory’s perspective |
dc.type | info:eu-repo/semantics/article |
dc.subject.decs | inhibidores de proteínas cinasas |
dc.subject.decs | /efectos adversos |
dc.subject.decs | quilotórax |
dc.subject.decs | /inducido químicamente |
dc.relation.publishversion | https://cms.ifcc.org/wp-content/uploads/2023/04/eJIFCC2023Vol34No1pp076-080.pdf |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Martínez RJG] Clinical Analysis Department, Marqués de Valdecilla University Hospital, Santander, Spain. Evidence-Based Laboratory Medicine Commission, Spanish Society of Laboratory Medicine (SEQCML), Barcelona, Spain. [Gea CS, Martin-Riera V, Ruiz ARG, Barzanti RP, Ferrer-Costa R, Ramirez-Serra C] Grup de Recerca de Bioquímica Clínica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Bioquímica Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 37124659 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |